To determine if the IL-32 promoter SNP was involved in both these parameters, genotypes and cholesterol levels were determined in RA patients (RA1 and RA2 cohort) with versus without a history in CVD (Fig. 4A–D). The gene discussed is IL32; the disease is rheumatoid arthritis.